Historical comparison of the efficacy and tolerability of third-generation regimens
aOnly the study of Scagliotti et al. [7] reported alopecia among toxicities; however, alopecia is a common side effect of docetaxel, with an incidence in the range of 60%–75%, depending on whether the drug is used as monotherapy or in combination with cisplatin.
Abbreviations: CBDCA, carboplatin; CDDP, cisplatin; Gem, gemcitabine; MS, median survival; NA, not applicable; PTX, paclitaxel; RR, response rate; TXT, docetaxel; VNB, vinorelbine.
Historical comparison of the efficacy and tolerability of third-generation regimens
aOnly the study of Scagliotti et al. [7] reported alopecia among toxicities; however, alopecia is a common side effect of docetaxel, with an incidence in the range of 60%–75%, depending on whether the drug is used as monotherapy or in combination with cisplatin.
Abbreviations: CBDCA, carboplatin; CDDP, cisplatin; Gem, gemcitabine; MS, median survival; NA, not applicable; PTX, paclitaxel; RR, response rate; TXT, docetaxel; VNB, vinorelbine.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.